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SOCS1 Deficiency Causes a Lymphocyte-Dependent
Perinatal Lethality
The SOCS proteins have been speculated to suppress
cytokine signaling based on overexpression studies. CIS
binds to the tyrosine phosphorylated erythropoietin re-
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ulated to induce a conformation change in the kinase
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The normal function for SOCS1 has been addressedSummary
by deriving mice that lack the gene (Naka et al., 1998;
Starr et al., 1998). Both studies described a perinatalSOCS1 is an SH2-containing protein that is primarily
lethality such that the mice die within 3 weeks. The basisexpressed in thymocytes in a cytokine- and T cell re-
for the lethality was not established, but acceleratedceptor±independent manner. SOCS1 deletion causes
apoptosis of lymphocytes was described and correlatedperinatal lethality with death by 2±3 weeks. During this
with increased Bax expression. In the other study, lethal-period thymic changes include a loss of cellularity and
ity was speculated to be due to an increased sensitivitya switch from predominantly CD41CD81 to single posi-
to interferon g (IFNg). We have also derived SOCS1-tive cells. Peripheral T cells express activation anti-
deficient mice and have observed a perinatal lethality.gens and proliferate to IL-2 in the absence of anti-CD3.
Here, we demonstrate that the perinatal lethality re-In addition, IFNg is present in the serum. Reconstitu-
quires lymphocytes as evidenced by the lack of lethalitytion of the lymphoid lineage of JAK3-deficient mice
in SOCS1-deficient mice also deficient in RAG2 and bywith SOCS1-deficient stem cells recapitulates the le-
the ability to transmit the lethality by reconstituting thethality and T cell alterations. Introducing a RAG2 or
lymphoid lineage of JAK3-deficient mice with SOCS1IFNg deficiency eliminates lethality. The results dem-
bone marrow stem cells. The potential roles of SOCS1onstrate that lymphocytes are critical to SOCS1-asso-
expression in T cells and the contribution to the perinatalciated perinatal lethality and implicate SOCS1 in lym-
lethality are discussed.phocyte differentiation or regulation.
Results
Introduction
Thymic Expression of SOCS1 Is
The SOCS family consists of relatively small proteins Developmentally Regulated
with a centrally located SH2 domain and a unique car- SOCS1 transcripts are highly expressed in thymus (Fig-
boxyl motif termed the SOCS box. The first family mem- ure 1A), to a much lower level in spleen, and not ex-
ber was termed the cytokine-inducible SH2-containing pressed in most other tissues. To assess the regulation
protein (CIS) (Yoshimura et al., 1995). Subsequently of expression, tissues from mutant mouse strains were
three groups, independently, identified the second fam- examined for SOCS1 protein by immunofluorescence,
ily member. One group cloned a gene encoding a JAK since levels of RNA do not take into consideration the
kinase±binding protein termed JAB (Endo et al., 1997). high rate of protein turnover (unpublished data). As illus-
The same gene product was identified by a relationship trated (Figure 1B), SOCS1 protein is highly expressed
of the SH2 domain to the SH2 domain of Stats and in normal thymocytes (ii), and this expression is in
termed SSI1 (Naka et al., 1997). Lastly, it was cloned as CD41CD81 thymocytes (data not shown). However, few
a gene product that blocks IL-6-induced differentiation if any cells in normal bone marrow (i), spleen (iii), or
and was termed SOCS for suppressor of cytokine signal- peripheral blood (iv) expressed SOCS1 protein. Thymo-
ing (Starr et al., 1997). Subsequently, additional family cyte expression was not affected by deficiency in the
members were identified in databases of expressed se- IL-7 receptor a chain (v), JAK3 (vi), or Stat5a/b (vii),
quences (Hilton et al., 1998). consistent with the lack of a role of cytokine signaling.
SOCS1 protein was also present in thymocytes from
RAG2-deficient mice (viii), indicating that T cell receptor# To whom correspondence should be addressed (e-mail: james.ihle@
stjude.org). signaling is not required. Together the results suggest
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610
Figure 1. SOCS1 Is Predominantly Expressed in Thymocytes and Is Developmentally Regulated
(A) Tissue distribution of SOCS1 transcripts were examined by Northern analysis.
(B) Immunofluorescence detection of SOCS1 expression in wild-type mice in the thymocyte population (ii), in bone marrow (i), splenocytes
(iii), or peripheral blood (iv). Immunofluorescence detection of SOCS1 expression is retained in thymocytes from IL-7R2/2 (v), JAK32/2 (vi),
Stat5ab2/2 (vii), and RAG22/2 (viii) mice.
that SOCS1 protein expression in thymocytes is devel- SOCS1-deficient mice had dramatically reduced num-
bers of B cells (K) relative to wild-type animals (H). Moreopmentally regulated.
strikingly, the peripheral splenic T cells had an activated
phenotype consisting of high levels of expression ofSOCS1 Deficiency Results in Alterations
CD25 (data not shown) and CD44 (L) as well as highin Thymocytes and Peripheral T Cells
levels of CD69, and, morphologically, the lymphocytesTo assess the potential role of SOCS1 expression in the
were large blasting cells (data not shown).thymus, we generated SOCS1-deficient mice. A tar-
The proliferative responses of peripheral T cells aregeting construct was utilized that deleted the entire
shown in Figure 2S. Splenic lymphocytes from SOCS1-SOCS1 coding sequence, resulting in mice with no de-
deficient mice showed some degree of spontaneoustectable SOCS1 protein. Consistent with previous stud-
proliferation in vitro. However, strikingly, the T cells pro-ies (Naka et al., 1998; Starr et al., 1998), SOCS1-deficient
liferated in response to IL-2 alone, and this was compa-mutant mice exhibited a perinatal lethality resulting in
rable to the response seen to the combination of anti-death by 3 weeks of age.
CD3 and IL-2. The thymic changes, the accumulationThe consequences of SOCS1 deletion on thymocytes
of peripheral T cells with an activated phenotype, theand peripheral T cells are shown in Figure 2. Within a
presence of T cells in bone marrow, and spontaneousfew days after birth, the numbers of thymocytes begin
proliferation are similar to those seen in mice lackingto decrease (data not shown). FACS analysis demon-
the critical negative regulator of T cell function, CTLA4strated a dramatic shift with age in the thymic popula-
(Tivol et al., 1995).tions from a decreased double positive population at 4
A critical, T cell±derived cytokine that could contributedays (Figure 2D) to an almost exclusively single positive
to the perinatal lethality is IFNg. As illustrated in Figurepopulation in 10-day-old SOCS1-deficient mice (E).
4B, all SOCS1-deficient mice had readily detectable lev-Moreover, the SOCS1-deficient mice had significant
els of IFNg in the serum that ranged from 50±300 pg/ml.numbers of CD41 and CD81 cells in bone marrow (P)
in contrast to normal littermates (M). In splenocytes, In contrast, heterozygous littermates lacked detectable
Lymphocytes Are Required for SOCS12/2 Lethality
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Figure 2. Flow Cytometric and Proliferative
Analysis of SOCS1-Deficient Mice
Thymus (A±F), spleen (G±L), and bone marrow
(M±R) cells were analyzed for the expression
of CD4 and CD8 (A, B, D, E, G, J, M, and P),
Thy1.2 and B220 (H, K, N, and Q), or CD4 and
CD44 (C, F, I, L, O, and R) by flow cytometry.
The cells depicted in (A) and (D) were derived
from 4-day-old mice, while the cells depicted
in (B) and (E) were derived from 10-day-old
mice. (C) and (F)±(R) were derived from mice
10 to 14 days of age. In (S), the proliferative
responses of spleen cells derived from wild-
type (1/1, solid bars) or SOCS1-deficient
(2/2, open bars) were determined after cul-
turing the cells in the presence of anti-CD3
(2C11, 2 mg/ml), rhuIL2 (100 U/ml), or both
stimuli combined.
levels of IFNg. The lymphocyte-specific origin of the reconstitute the lymphoid lineages in sublethally irradi-
ated JAK3-deficient mice. Under these conditions, theIFNg is demonstrated by the absence of detectable se-
rum levels of IFNg in SOCS1-deficient mice that are also lymphoid lineages are reconstituted while myeloid lin-
eages are derived from host progenitors (Bunting et al.,deficient in RAG2 (Figure 4B). Taken together, the results
suggest that the SOCS1 deficiency results in altered T 1998; Parganas et al., 1998). As illustrated in Figure 3A,
JAK3-deficient mice reconstituted with bone marrowcell differentiation or regulation leading to IFNg pro-
duction. from wild-type mice (open circles) or SOCS1-deficient
mice (closed circles) progressively developed peripheral
lymphocytes beginning at about 30 days after trans-SOCS1-Deficient Lymphoid Stem Cells Can Confer
the Lethality and T Cell Alterations plantation. As anticipated from numerous such experi-
ments, there was no lethality seen in mice reconstitutedto JAK3-Deficient Mice
In order to attempt to study the role of SOCS1 in lympho- with wild-type bone marrow cells or with bone marrow
from mice heterozygous for the SOCS1 deficiency (datacytes, independent of functions in other cell types, we
used bone marrow cells from SOCS1-deficient mice to not shown). However, strikingly, JAK3-deficient mice
Cell
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Figure 3. The Lethality Associated with
SOCS1 Deficiency Can Be Transferred to
JAK3-Deficient Mice with Bone Marrow Cells
(A) SOCS11/1 or 1/2 and 2/2 bone marrow
cells were used to reconstitute sublethally ir-
radiated JAK3-deficient mice. As the white
blood counts (WBC) increased with time, all
the chimeric animals reconstituted with
SOCS12/2 cells (closed dots) died progres-
sively, whereas the control animals (open
dots) survived for more than 3 months. (B)
PCR amplification of a SOCS1-specific mu-
tated allele fragment from T cells isolated
from two chimeric animals reconstituted with
SOCS12/2 or SOCS11/1 bone marrow cells.
Splenocytes derived from JAK3-deficient re-
cipients reconstituted with wild-type (1/1) or
SOCS1-deficient (2/2) cells were stained
with (C) FITC-anti-Thy1.2 and PE-anti-B220,
or (D) FITC anti-CD4 and PE anti-CD8, or (E)
FITC anti-CD44 and PE anti-CD4 prior to anal-
ysis in the flow cytometer.
reconstituted with bone marrow from homozygously this possibility, we crossed RAG2-deficient mice with
SOCS1-deficient mice. As illustrated in Figure 4A, miceSOCS1-deficient mice died progressively, concomitant
with lymphoid reconstitution as indicated by PCR analy- homozygously deficient in both RAG2 and SOCS1 sur-
vive, while the presence of a functional RAG2 allele onsis (Figure 3B).
On examination of the reconstituted mice, the a SOCS1-deficient background results in perinatal le-
thality. Therefore, the ability to generate a functionalchanges in peripheral T cells seen in SOCS1-deficient
mice were also present. In particular, mice reconstituted antigen receptor is essential for the perinatal lethality.
Since T cell±derived IFNg could be speculated to be awith either wild-type or SOCS1-deficient bone marrow
had splenic CD41 and CD81 cells (Figure 3D). However, critical factor in the perinatal lethality, we also derived
mice deficient in both SOCS1 and IFNg. As illustratedas illustrated in Figure 3E, the repopulating CD41 T cells
from SOCS1-deficient bone marrow all expressed the in Figure 4A, these mice similarly survived long term.
activation antigen, CD44. Also similar to the SOCS1-
deficient mice, there were few detectable B220-positive Discussion
B cells (Figure 3C). The general pathology observed in
the mice was comparable to that seen in the SOCS1- Our results establish that the perinatal lethality associ-
ated with SOCS1 deficiency requires lymphocytes. Thedeficient mice (data not shown). The results demon-
strate that the lethality seen in the SOCS1-deficient mice evidence is derived from both the elimination of lethality
by introducing a RAG2 deficiency as well as by thecan be mediated by lymphocytes on a background in
which the SOCS1 gene is present in other cell types. ability to transfer lethality by reconstituting the lymphoid
compartment of JAK3-deficient mice with SOCS1-defi-
cient cells. It is unlikely that B cells contribute to theRAG2 or IFNg Deficiency Eliminates the Lethality
Associated with SOCS1 Deficiency pathology, since there is a striking depletion of B cells
in both SOCS1-deficient mice and in JAK3 mice recon-The above results prompted us to determine whether
the elimination of functional lymphocytes might elimi- stituted with SOCS1-deficient cells. The high serum lev-
els of IFNg would implicate T cells, since they are thenate the lethality in SOCS1-deficient mice. To address
Lymphocytes Are Required for SOCS12/2 Lethality
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Figure 4. Requirement for Antigen Recep-
tors and IFNg in the Perinatal Lethality of
SOCS1-Deficient Mice
(A) The lethality of SOCS1-deficient mice is
eliminated on a RAG2- or IFNg-deficient
background. The percentage survivals with
time are shown for SOCS1-deficient (solid cir-
cles) versus wild-type or mice heterozygous
for the SOCS1 deletion (open circles), mice
deficient in both SOCS1 and IFNg (solid
squares), mice deficient in SOCS1 and homo-
zygous or heterozygous for the IFNg wild-
type allele (open squares), mice deficient in
both SOCS1 and RAG2 (solid diamonds), and
mice deficient in SOCS1 and either heterozy-
gous or homozygous for the wild-type RAG2
allele (open diamonds).
(B) IFNg serum levels in SOCS1-deficient
mice. The presence of IFNg in the serum of
individual SOCS1-deficient, wild-type, IFNg-
deficient, SOCS1- and IFNg-deficient, or
SOCS1- and RAG2-deficient mice was deter-
mined by ELISA of the serum samples using
a kit purchased from Endogen. The absor-
bency values for the samples were plotted
against a standard curve (provided in the kit)
to calculate the level of IFNg in units of pg/ml.
predominant source of IFNg. Lastly, the peripheral T abnormal T cells produce cytokines, including IFNg, and
cells in SOCS1-deficient mice exhibit an activated phe- in the absence of negative regulation, the IFNg induces
notype and respond to cytokines in the absence of TCR pathological levels of other inflammatory cytokines re-
stimulation, suggesting that SOCS1 deficiency causes sulting in lethality. The recapitulation of the pathology
some type of an alteration in T cell differentiation or in reconstituted JAK3-deficient mice would suggest that
regulation. SOCS1 deficiency in nonlymphoid tissues is not essen-
The elimination of lethality with IFNg deficiency tial for lethality.
strongly suggests that IFNg is critical for the pathology. Although the lethality occurs in reconstituted JAK3
Moreover, the absence of detectable IFNg in RAG2/ mice, none of our studies directly addressed the ques-
SOCS1-deficient mice establishes lymphocytes as the tion of an increase in IFNg signaling in nonlymphoid
source. Administration of high doses of IFNg in neonatal tissues and its contribution to pathology. To examine
mice produces a fatal syndrome of fatty degeneration this issue, in preliminary experiments, we have com-
and necrosis of the liver and thymus atrophy (Gresser pared the sensitivity of RAG2/SOCS1-deficient mice
et al., 1981). However, transgenic strains of mice pro- with RAG2-deficient mice to intraperitoneal injections
ducing levels of IFNg that are comparable to those we of IFNg. With daily injections of 105 units of IFNg, a
observe in SOCS1-deficient mice do not have an acute nonlethal dose in wild-type mice (Mattsson et al., 1992),
pathology (Young et al., 1997). Importantly, there is a RAG2-deficient mice survive while RAG2/SOCS1-defi-
depletion of B cells in the transgenic mice similar to cient mice die after the second injection at 30±36 hr.
SOCS1-deficient mice. This suggests that normal B This would suggest that increased IFNg signaling in non-
cells, irrespective of the presence or absence of SOCS1, lymphoid tissues can contribute to pathology.
are particularly sensitive to IFNg. In addition, transgenic
T cell±derived IFNg may also synergize with other T
expression of IFNg has been reported to cause a chronic
cell±derived cytokines to produce the perinatal lethality.hepatitis (Toyonaga et al., 1994) that may result from
This possibility is supported by the similarity of theincreased TNFa (Okamoto et al., 1996).
SOCS1 perinatal lethality with that seen in CTLA4-defi-The acute pathology could be due to a generalized
cient mice (Tivol et al., 1995). In particular, these miceincreased IFNg signaling in the absence of SOCS1. IFNg
survive only 2±3 weeks, have comparable levels of circu-induces SOCS1 RNA in fibroblasts or M1 cells (Saka-
lating IFNg, show comparable changes in thymocytemoto et al., 1998), and when overexpressed it can sup-
populations, and have peripheral T cells expressing acti-press cytokine signaling, including IFNg, by inhibiting
vation antigens. Because of these similarities, a moreJAK kinases (Yasukawa et al., 1999). Since IFNg is an
detailed histological comparison of these two perinatalinducer of a wide variety of genes that influence inflam-
lethalities will be of interest.matory responses, including inflammatory cytokines
The results demonstrate that IFNg production by lym-such as TNFa and its receptor (Boehm et al., 1997),
phocytes is required for the perinatal lethality. Thus, aSOCS1 suppression of signaling would block this pro-
duction. Thus, one could envision a scenario in which critical question is whether this production is mediated
Cell
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Experimental Proceduresby normal T cells or by T cells that are altered in differen-
tiation or regulation. The possibility that T cells are al-
Genotyping of SOCS1-Deficient Micetered by SOCS1 deficiency is suggested by the presence
by Southern Blot and PCR
of peripheral T cells expressing activation antigens as Genotyping was by Southern blot analysis or using PCR. Approxi-
well as proliferating to cytokines in the absence of anti- mately 200 ng of mouse tail DNA or genomic DNA was amplified
CD3. In addition, the presence of detectable serum lev- per 25 ml reaction using 2.0 U of Qiagen Taq-polymerase in a final
concentration of each dNTP at 0.2 mM, MgCl2 at 1.5 mM. The PCRels of IFNg would support the conclusion that some type
primers consisted of P1 primer (59-CAGGCACCCACTCCTGGCCTT),of alteration of T cell differentiation or function exists.
P2 (59-TGGCCATTCGGCCTGGCCTT), and the neomycin primer P3A role for SOCS1 in T cell differentiation is suggested
(59-GCCTTCTTGACGAGTTCTTCTG). The PCR cycle profile was as
by the high protein levels in thymocytes. Unlike expres- follows: 1 cycle at 948C for 4 min followed by 35 cycles at 948C for
sion in many cell types, this expression does not require 1 min, 648C for 30 s, 728C for 1 min; and finally 1 cycle at 728C for
cytokine signaling. In particular, SOCS1 is still highly 5 min. A 350 bp fragment indicates the presence of the wild-type
allele, whereas a 175 bp fragment is amplified from the mutatedexpressed in thymocytes lacking JAK3, a kinase that is
allele.required for IL-7 and IL-2 signal transduction as well as
other cytokines that utilize the common g chain of the
IL-2 receptor (Nosaka et al., 1995; Thomis et al., 1995). Histology and Immunofluorescence
Thymi were dissected from wild-type, IL-7 receptor2/2, JAK32/2,Similarly, thymocytes from RAG2-deficient mice ex-
Stat5ab2/2, and RAG22/2 animals. Single-cell preparations of thy-press SOCS1, suggesting that T cell receptor signaling
mocytes from each strain were prepared by finely dicing thymicis not involved in its regulation. Moreover, the lack of
tissue and passing through a 70 mm, nylon cell strainer. Single-cell
comparable expression in bone marrow or peripheral suspensions were also prepared from bone marrow and spleen
T cells suggests that the expression in thymocytes is extracted from wild-type mice. Cells from thymi, spleen, and bone
regulated with differentiation. marrow were washed twice in PBS and resuspended at a concentra-
tion of 5 3 106 cells/ml. Single-cell suspensions were transferredIrrespective of regulation, the question to be ad-
onto gelatin-coated glass slides in 20 ml aliquots and allowed to drydressed is the role of thymic SOCS1 expression. Since
at room temperature. Peripheral blood smears were also preparedSOCS1 inhibits cytokine signaling, it can be speculated
from wild-type mice. Expression of SOCS1 protein levels in all cellthat cytokine signaling is suppressed by SOCS1 in thy-
preparations were detected using a goat anti-mouse SOCS1 primary
mocytes. Such a function may account for the inability antibody (Santa Cruz) and Alexa488-anti-rabbit polyclonal secondary
of double positive thymocytes to proliferate in response antibody (Molecular Probes). Briefly, cell preparations were fixed
to anti-CD3 and cytokines (Suda et al., 1990; Shi et al., for 20 min in 10% buffered formalin (Fisher), blocked for 1 hr in a
solution of 10% BSA in 13 PBS, followed by overnight incubation1991; Lerner et al., 1996; Hettmann et al., 1999). We
at 48C with a 1:50 dilution of primary anti-SOCS1 antibody. Slideshave recently tested this hypothesis by deriving trans-
were washed with 13 PBS and incubated for a further 2 hr at roomgenic mice that aberrantly express SOCS1 throughout
temperature with a 1:50 dilution of Alexa488-anti-rabbit antibody.
lymphocyte differentiation (unpublished data). Bone Slides were washed three times with 13 PBS and mounted under
marrow cells and thymocytes from such mice fail to glass coverslips using Antifade-Fluoromount (Fisher). SOCS1 ex-
proliferate in response to IL-7, and peripheral T cells fail pression levels were visualized by confocal microscopy using a
Leica DM-IRBE microscope together with Leica TCS-NT software.to proliferate in response to IL-2. Overall the lack of
cytokine responses are comparable to that seen in
JAK1- (Rodig et al., 1998) or JAK3- (Nosaka et al., 1995; Reconstitution
Thomis et al., 1995) deficient lymphocytes. Bone marrow cells from wild-type or SOCS1-deficient mice were
used to reconstitute sublethally irradiated JAK3-deficient mice (900If SOCS1 suppresses cytokine signaling in the major
Rads). Approximately 2 3 106 cells in 500 ml of PBS containing 2%thymocyte population, it is interesting to speculate on
of fetal bovine serum were injected into the tail blood vessel of thethe possible significance. First, suppression of cytokine
recipient animals.signaling may protect the cells from the effects of IFNg.
As illustrated by transgenic mice (Young et al., 1997)
Flow Cytometry and Proliferative Responsesexpressing IFNg, B cells are extremely sensitive to IFNg,
Thymus, spleen, and bone marrow were sampled from individualwhile thymocytes are resistant, although at high levels
mice and made into single-cell suspensions in PBS supplementedof IFNg they become sensitive (Gresser et al., 1981). with 1% bovine serum albumin (PBS/BSA). Aliquots of 2 3 105 cells
The higher resistance of thymocytes may be due to were stained with cocktails of mAbs in PBS/BSA conjugated to
expression of SOCS1. Consistent with this, there is a fluorescein isothyocyanate (FITC), phycoerythrin (PE), or biotin for
dramatic loss of thymocytes in SOCS1-deficient mice. 30 min at 48C. The cells were washed with PBS/BSA, and the biotinyl-
ated antibodies were developed with streptavidin conjugated to redThe consequences of SOCS1 inhibition of other cyto-
670 (Life Technologies, Gaithersburg, MD). The stained cells werekines in thymocytes, such as IL-7 and IL-2, should also
analyzed in a Becton Dickinson FACScan in three-color mode usingbe considered. In particular, it may be essential for nor-
CellQuest software. The antibodies used were RM4-4 to CD4, 53-
mal T cell differentiation and/or selection to suppress 6.7 to CD8a, 31-H12 to Thy1.2, RA3-6B2 to B220, and IM7 to CD44.
cytokine signaling at a specific stage of development. All mAbs were purchased from PharMingen (San Diego, CA) and
Such possibilities are being explored. can be referenced in their current catalog.
In summary, the results are consistent with a model To assess the proliferative capacity of the cells, 105 spleen or
thymus cells were plated per well in 96-well round-bottomed platesin which SOCS1 has two essential functions that, when
(Falcon) in 100 ml SMEM (Life Technologies, Gaithersburg, MD) sup-disrupted, result in perinatal lethality. One function is to
plemented with 10% fetal bovine serum (Atlanta Biologicals, Nor-regulate T cell differentiation or function to suppress the
cross, GA), L-glutamine, penicillin, streptomycin, gentamycin (all
emergence of activated T cells that produce IFNg. The from Life Technologies), sodium bicarbonate (Sigma, St. Louis, MO),
second function is to terminate IFNg signaling in both essential and nonessential amino acids (Life Technologies), and
lymphoid and nonlymphoid cells to control the produc- 2-mercaptoethanol (Sigma). The cells were stimulated as indicated
with anti-CD3 (2C11, PharMingen, San Diego, CA), recombinant humantion of inflammatory cytokines such as TNFa.
Lymphocytes Are Required for SOCS12/2 Lethality
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IL-2 (Chiron, Emeryville, CA), or recombinant murine IL-7 (R&D Sys- Koyasu, S., Bhan, A.K., and Reinherz, E.L. (1996). Cross-linking of
T-cell receptors on double-positive thymocytes induces a cytokine-tems, Minneapolis, MN). Proliferation was assessed 72 hr after the
start of the culture by measuring the incorporation of 3H-thymidine mediated stromal activation process linked to cell death. EMBO J.
15, 5876±5887.(Amersham Life Sciences, Arlington Heights, IL) added during the
last 18 hr of the culture. Mattsson, R., Mattsson, A., Holmdahl, R., Scheynius, A., and van
der Meide, P.H. (1992). In vivo treatment with interferon-gamma
Measurement of IFNg during early pregnancy in mice induces strong expression of major
To assess production of IFNg, spleen or thymus cell populations histocompatibility complex class I and II molecules in uterus and
were cultured for 6 hr in 96-well round-bottomed plates at 1 3 106 decidua but not in extra-embryonic tissues. Biol. Reprod. 46, 1176±
cells per well in complete medium containing 10 mg/ml Brefeldin-A 1186.
(Epicenter Technologies, Madison, WI) with either medium alone, 4 Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S.,
mg/ml anti-CD3 (2C11, PharMingen, San Diego, CA), 100 U/ml rhuIL2 Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S.,
(Chiron, Emeryville, CA), or both anti-CD3 and IL-2. After culture, and Kishimoto, T. (1997). Structure and function of a new STAT-
the cells were placed on ice, washed in PBS/Brefeldin-A (10 mg/ induced STAT inhibitor. Nature 387, 924±929.
ml), stained with a cocktail of anti-CD4-FITC and anti-CD8-tricolor
Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y.,as above, washed again, and fixed with 1% formaldehyde. The cells
Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., and Kishimoto,were permeablized in 0.5% saponin (Sigma, St Louis, MO) before
T. (1998). Accelerated apoptosis of lymphocytes by augmented in-staining with anti-IFNg-PE (PharMingen) for 30 min on ice. The cells
duction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficientare then washed and analyzed in three-color mode on the FACScan
mice. Proc. Natl. Acad. Sci. USA 95, 15577±15582.as above. The presence of IFNg in the serum was determined by
Nosaka, T., van Deursen, J.M.A., Tripp, R.A., Thierfelder, W.E., Wit-ELISA using a kit provided by Endogen (Woburn, MA).
thuhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle,
J.N. (1995). Defective lymphoid development in mice lacking Jak3.Northern Analysis
Science 270, 800±802.Total RNA was prepared from thymi and bone marrow of wild-type
and SOCS1-deficient mice as well as from various tissues of wild- Okamoto, T., Furuya, M., Yamakawa, T., Yamamura, K., and Hino,
type or SOCS1 transgenic mice using the RNA-zol-B purification O. (1996). TNFa gene expression in the liver of IFNg transgenic
method (Tel-test). For the Northern blotting, 20 mg RNA per lane mouse with chronic active hepatitis. Biochem. Biophys. Commun.
was separated on 1% formaldehyde agarose gel and blotted. The 226, 762±768.
SOCS1 and actin probes were PCR products amplified from cloned Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.-C.,
full-length cDNA. Both probes were subsequently labeled using a Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen,
random priming kit readyprime (Amersham). The membranes were J.M., et al. (1998). Jak2 is essential for signaling through a variety
washed in 50 mM phosphate buffer, 5% SDS, 1 mM EDTA at 608C of cytokine receptors. Cell 93, 385±395.
for 30 min.
Rodig, S.J., Meraz, M.A., White, J.M., Lampe, P.A., Riley, J.K., Arthur,
C., King, K.L., Sheehan, K.C.F., Yin, L., Pennica, D., et al. (1998).
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